Expression of vascular endothelial growth factor in human monocyte/macrophages stimulated with lipopolysaccharide

Thrombosis and Haemostasis

Volumn 85, Issue 1, 2001, Pages 171-176

  Itaya, H ^a   Imaizumi, T ^a   Yoshida, H ^a   Koyama, M ^a   Suzuki, S ^a   Satoh, K ^a  

^a HIROSAKI UNIVERSITY   (Japan)

Author keywords

AP 1; c jun; Human macrophages; Lipopolysaccharide; p38 MAP kinase; Vascular endothelial growth factor

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; CYCLOHEXIMIDE; LIPOPOLYSACCHARIDE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN C JUN; TRANSCRIPTION FACTOR AP 1; VASCULOTROPIN;

ARTICLE; BINDING SITE; CELL STIMULATION; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; MACROPHAGE ACTIVATION; MONOCYTE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; RECEPTOR UPREGULATION; TRANSCRIPTION REGULATION;

EID: 0035169825     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1612921     Document Type: Article

References (33)

1. Vascular endothelial growth factor is a secreted angiogenic mitogen
2. Vascular permeability factor, an endothelial cell mitogen related to PDGF
3. Angiogenesis in cancer, vascular, rheumatoid and other disease
4. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders
5. Modulation of angiogenic vascular endothelial growth factor by tumor necrosis factor a and interleukin-1 in rheumatoid arthritis
6. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumor growth in vivo
7. Controlled delivery of vascular endothelial growth factor promotes neovascularization and maintains limb function in a rabbit model of ischemia
8. Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms
9. The human gene for vascular endothelial growth factor: Multiple protein forms are encoded through alternative exon splicing
10. The vascular endothelial growth factor (VEGF) isoforms: Differential deposition into the subepithelial extracellular matrix and bioactivity of extracellular matrix-bound VEGF
11. Vascular endothelial growth factor is induced in response to transforming growth factor-β in fibroblastic and epithelial cells
12. Induction of vascular endothelial growth factor gene expression by interleukin-1b in rat aortic smooth muscle cells
13. Indirect angiogenic cytokines upregulate VEGF and bFGF gene expression in vascular smooth muscle cell, whereas hypoxia upregulates VEGF expression only
14. Hypoxia induces vascular endothelial growth factor in cultured human endothelial cells
15. Vascular endothelial growth factor mRNA increases in alveolar epithelial cells during recovery from oxygen injury
16. Intracellular pool of vascular endothelial growth factor in human neutrophils
17. Vascular endothelial growth factor is produced by peritoneal fluid macrophages in endometriosis and is regulated by ovarian steroids
18. Production of vascular endothelial growth factor by murine macrophages: Regulation by hypoxia, lactate, and the inducible nitric oxide synthase pathway
19. Isolation of mononuclear cells and granulocytes from human blood
20. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis
21. Induction of vascular endothelial growth factor by tumor necrosis factor a in human glioma cells: Possible roles of SP-1
22. Possible participation of autocrine and paracrine vascular endothelial growth factors in hypoxia-induced proliferation of endothelial cells and pericytes
23. Expression of tumor-necrosis factor-α in cultured human endothelial cells stimulated with lipopolysaccharide or interleukin-1a
24. Endothelial cells for studies of platelet-activating factor and arachidonate metabolites
25. Endotoxin-induced macrophage gene expression depends on platelet-activating factor
26. The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation
27. Activation of the transcription factor MEF2C by the MAP kinase p38 in inflammation
28. Interaction of nuclear proteins with an AP-1/CRE-like promoter sequence in the human TNF-alpha gene
29. Mechanism of lipopolysaccharide-triggered junB activation in a mouse macrophage-like cell line (J774)
30. Inhibition of MAP kinase kinase prevents cytokine and prostaglandin E2 production in lipopolysaccharide-stimulated monocytes
31. Glucocorticoids repress ribosome biosynthesis in lymphosarcoma cells by affecting gene expression at the level of transcription, posttranscription and translation
32. Molecular mechanisms of dexamethasone inhibition of nitric oxide synthase expression in interleukin 1β- stimulated mesangial cells: Evidence for the involvement of transcriptional and posttranscriptional regulation
33. Hypoxic stabilization of vascular endothelial growth factor mRNA by the RNA-binding protein HuR